David A. Siegel Ars Pharmaceuticals, Inc. Comm Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q3 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Ars Pharmaceuticals, Inc. Comm stock. As of the latest transaction made, Two Sigma Advisers, LP holds 41,400 shares of SPRY stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares

41,400

Previous 24,300 70.37%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	N/A	17,100 Added 70.37%	41,400 $0
Q2 2024 Aug 14, 2024	BUY	N/A	24,300 New	24,300 $0
Q2 2023 Aug 14, 2023	BUY	N/A	6,000 Added 2.72%	226,800 $0
Q1 2023 May 15, 2023	SELL	N/A	-23,300 Reduced 9.55%	220,800 $0
Q4 2022 Feb 14, 2023	SELL	N/A	-25,700 Reduced 9.53%	244,100 $0
Q3 2022 Nov 14, 2022	SELL	N/A	-156,900 Reduced 36.77%	269,800 $1.43 Million
Q2 2022 Aug 15, 2022	BUY	N/A	55,900 Added 15.08%	426,700 $1.81 Million
Q1 2022 May 16, 2022	BUY	N/A	144,100 Added 63.56%	370,800 $1.3 Million
Q4 2021 Feb 14, 2022	BUY	N/A	189,100 Added 502.93%	226,700 $1.51 Million
Q3 2021 Nov 15, 2021	BUY	N/A	37,600 New	37,600 $375,000

About ARS PHARMACEUTICALS, INC. COMM

Ticker SPRY

More about SPRY

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account